HSR26-204: Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials

Ahmad Y. Abuhelwa; Sara A. Almansour; Humaid O. Al-Shamsi; Ziad Abuhelwa; Mohamad A. Ziade; Ross A. McKinnon; Michael J. Sorich; Ashley M. Hopkins

doi:10.6004/jnccn.2025.7459

HSR26-204: Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials

Ahmad Y. Abuhelwa
, Sara A. Almansour
, Humaid O. Al-Shamsi
, Ziad Abuhelwa
, Mohamad A. Ziade
, Ross A. McKinnon
, Michael J. Sorich
, Ashley M. Hopkins

University of Sharjah

University of Sharjah
Harvard University
University of South Florida
Medcare Royal Specialty Hospital
Flinders University

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	24
Issue number	35
DOIs	https://doi.org/10.6004/jnccn.2025.7459
State	Published - 31 Mar 2026

Access to Document

10.6004/jnccn.2025.7459

Cite this

Abuhelwa, A. Y., Almansour, S. A., Al-Shamsi, H. O., Abuhelwa, Z., Ziade, M. A., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2026). HSR26-204: Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials. Journal of the National Comprehensive Cancer Network : JNCCN, 24(35). https://doi.org/10.6004/jnccn.2025.7459

@article{c69b06c8db8c46a9baa0eab01cd4a48b,

title = "HSR26-204: Baseline EORTC QLQ-C30 {"}Clinically Important{"} Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials",

author = "Abuhelwa, \{Ahmad Y.\} and Almansour, \{Sara A.\} and Al-Shamsi, \{Humaid O.\} and Ziad Abuhelwa and Ziade, \{Mohamad A.\} and McKinnon, \{Ross A.\} and Sorich, \{Michael J.\} and Hopkins, \{Ashley M.\}",

year = "2026",

month = mar,

day = "31",

doi = "10.6004/jnccn.2025.7459",

language = "English",

volume = "24",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "35",

}

Abuhelwa, AY, Almansour, SA, Al-Shamsi, HO, Abuhelwa, Z, Ziade, MA, McKinnon, RA, Sorich, MJ & Hopkins, AM 2026, 'HSR26-204: Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 24, no. 35. https://doi.org/10.6004/jnccn.2025.7459

HSR26-204: Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials. / Abuhelwa, Ahmad Y.; Almansour, Sara A.; Al-Shamsi, Humaid O. et al.
In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 24, No. 35, 31.03.2026.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - HSR26-204

T2 - Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials

AU - Abuhelwa, Ahmad Y.

AU - Almansour, Sara A.

AU - Al-Shamsi, Humaid O.

AU - Abuhelwa, Ziad

AU - Ziade, Mohamad A.

AU - McKinnon, Ross A.

AU - Sorich, Michael J.

AU - Hopkins, Ashley M.

PY - 2026/3/31

Y1 - 2026/3/31

UR - https://www.scopus.com/pages/publications/105034818137

U2 - 10.6004/jnccn.2025.7459

DO - 10.6004/jnccn.2025.7459

M3 - Article

C2 - 41911764

AN - SCOPUS:105034818137

SN - 1540-1405

VL - 24

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 35

ER -

HSR26-204: Baseline EORTC QLQ-C30 "Clinically Important" Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials

Access to Document

Other files and links

Cite this